Home

Patrick D. Yeramian, Chief Medical Officer: Amylyx Pharmaceuticals AMLX Sell · Filed 23/04/19

Trade details

Type
Insider sale
Amount
$9,282
Shares · price
300 sh · $30.94 a share
Held after
208,417 sh
Trade date
23/04/17
Filed
23/04/19
Days to filing
2 days

Sold 0.1% of holdings

Share of holding sold
0.1%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/03/18~23/05/17

Patrick D. Yeramian's recent trades

  • Patrick D. Yeramian

    SellAmylyx Pharmaceuticals

    $45.9K

    Filed 24/01/11

  • Patrick D. Yeramian

    Sell10b5-1 planAmylyx Pharmaceuticals

    $347.3K

    Filed 23/05/17

  • Patrick D. Yeramian

    Sell10b5-1 planAmylyx Pharmaceuticals

    $1.5M

    Filed 23/04/19

  • Patrick D. Yeramian

    SellAmylyx Pharmaceuticals

    $1.7M

    Filed 23/03/24

  • Patrick D. Yeramian

    SellAmylyx Pharmaceuticals

    $78.4K

    Filed 23/03/24

Patrick D. Yeramian, Chief Officer — sold $9,282 of Amylyx Pharmaceuticals AMLX · 0.1% of holdings · 10b5-1 plan | Whalegun